Jim Simons Jaguar Health, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.08 - $809.55 $16,696 - $169 Million	208,700 Added 28.59%	938,747 $82,000
Q3 2022 Nov 14, 2022	SELL	$0.17 - $765.0 $77,638 - $349 Million	-456,697 Reduced 38.48%	730,047 $114,000
Q2 2022 Aug 12, 2022	SELL	$0.27 - $0.71 $90,788 - $238,739	-336,253 Reduced 22.08%	1,186,744 $349,000
Q1 2022 May 13, 2022	BUY	$0.38 - $1.07 $578,738 - $1.63 Million	1,522,997 New	1,522,997 $1.08 Million
Q4 2021 Feb 11, 2022	SELL	$1.03 - $2.48 $1.09 Million - $2.62 Million	-1,055,397 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.14 - $4.95 $2.26 Million - $5.22 Million	1,055,397 New	1,055,397 $2.4 Million

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $127M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.